Boltz Lab

Boltz Lab is an AI-powered computational drug discovery platform designed to help scientists accelerate the journey from hit identification to lead optimization. Built by Boltz, the platform brings together frontier AI models and intelligent agents into a single unified environment, enabling researchers across the life sciences to reshape biology through the power of machine learning.

The Boltz Platform is underpinned by open-source biomolecular models trusted by hundreds of thousands of researchers, with over one million downloads, more than 3,000 GitHub stars, and a Slack community of over 4,000 members. This open-source foundation ensures that the agents powering the platform are battle-tested, widely adopted, and freely available to the research community.

Core Platform Capabilities

• Target Definition: Define and refine biological targets with AI assistance, enabling scientists to focus their discovery efforts with greater precision.
• Distributed Design: Run large-scale molecular screening campaigns across distributed infrastructure, dramatically reducing the time required for exploration.
• Iterative Refinement: Integrate experimental data back into the platform to continuously improve model outputs and guide lead optimization cycles.

AI Agents

• Small Molecule Agent: An AI-powered screening agent capable of exploring vast chemical spaces in hours rather than months, accelerating small molecule drug discovery workflows.
• Protein Design Agent: Enables the design of novel proteins with precision, validated across a wide variety of modalities and biological targets.

Underlying Open-Source Models

• Boltz-1: A widely adopted open-source all-atom co-folding model, delivering results up to 1,000 times faster than traditional approaches.
• Boltz-2: Described as the world's best AI affinity prediction model, approaching the accuracy of Free Energy Perturbation (FEP) methods while operating 1,000 times faster.
• BoltzGen: A universal binder design model capable of designing proteins to arbitrary targets, supporting broad applicability across drug discovery programs.

Boltz partners with pioneering research teams to tackle the most challenging problems in drug discovery, offering collaborative engagements to accelerate research programs. The platform is available to try directly through Boltz Lab, providing immediate access to AI-powered drug discovery capabilities.